KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Invested Capital (2016 - 2025)

Historic Invested Capital for Pacira BioSciences (PCRX) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Pacira BioSciences' Invested Capital fell 1742.82% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 1742.82%. This contributed to the annual value of $1.4 billion for FY2024, which is 207.52% down from last year.
  • According to the latest figures from Q3 2025, Pacira BioSciences' Invested Capital is $1.1 billion, which was down 1742.82% from $1.3 billion recorded in Q2 2025.
  • Pacira BioSciences' 5-year Invested Capital high stood at $1.8 billion for Q4 2021, and its period low was $802.5 million during Q1 2021.
  • Its 5-year average for Invested Capital is $1.3 billion, with a median of $1.4 billion in 2024.
  • As far as peak fluctuations go, Pacira BioSciences' Invested Capital soared by 11663.1% in 2021, and later plummeted by 1905.62% in 2023.
  • Pacira BioSciences' Invested Capital (Quarter) stood at $1.8 billion in 2021, then decreased by 17.71% to $1.5 billion in 2022, then fell by 4.91% to $1.4 billion in 2023, then decreased by 2.08% to $1.4 billion in 2024, then fell by 19.05% to $1.1 billion in 2025.
  • Its Invested Capital stands at $1.1 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.4 billion for Q1 2025.